“…It is known that severe oxidative stress does not only cause damage and mutation in tumour suppressor genes, but also plays a significant role in carcinogenesis [7,8]. In addition, there are studies suggesting that antioxidant levels such as vitamin E, vitamin C, superoxide dismutase and catalase are decreased in the plasma of patients with ovarian cancer, whereas these patients also display increased lipid peroxidation and oxidative stress levels [7,21,22]. In our study, in which we investigated whether there was a difference in oxidative stress among the EOC, the BOT and the control group, we found that the oxidative stress markers TOS and OSI were significantly higher, whereas TAS levels were significantly lower in patients with EOC.…”